放射線治療計画　―準備から照射まで―

出版社： ピラールプレス
著者：
発行日： 2018-02-26
分野： 臨床医学：一般  >  放射線/核医学
ISBN： 9784861941931
電子書籍版： 2018-02-26 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

6,600 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

6,600 円(税込)

購入する

商品紹介

本書は,放射線治療に携わる診療放射線技師が,どのような流れで治療の準備が始まり,照射に至るのか日頃の手順をまとめたものです.疾病ごとに(1)概要(2)放射線治療の適応(3)標的体積(4)治療計画(5)治療成績(6)有害事象と対処法・治療中の注意点と6項目に分類して,日頃,治療精度向上のために気をつけるべきポイントやコツ,また治療の過程によって生じる一般的な有害事象を整理して記載しました.　また,看護サイドからみた生活上の注意点もまとめ,放射線治療を受ける患者が気持ちよく治療を終えられるよう,放射線治療に携わる診療放射線技師,看護師の入門書として作成しました.

目次

  • 用語解説

    Chapter 1　中枢神経系
    　1 悪性神経膠腫
    　2 低悪性度神経膠腫
    　3 髄芽腫
    　4 脳胚腫
    　5 上衣腫
    　6 下垂体腺腫
    　7 聴神経腫瘍
    　8 髄膜腫
    　9 脊髄腫瘍

    Chapter 2　頭頸部
    　1 眼・眼窩腫瘍
    　2 上顎癌
    　3 舌以外の口腔癌
    　4 上咽頭癌
    　5 中咽頭癌
    　6 下咽頭癌
    　7 喉頭癌
    　8 唾液腺腫瘍
    　9 舌癌

    Chapter 3　胸　部
    　1 非小細胞肺癌
    　2 小細胞肺癌
    　3 肺癌に対する定位放射線治療
    　4 肺癌 CTVアトラス
    　5 縦隔腫瘍
    　6 乳癌 ─乳房温存療法─
    　7 乳癌 ─乳房切除術後放射線治療─

    Chapter 4　消化器
    　1 食道癌
    　2 胸部食道癌リンパ節領域 CTVアトラス
    　3 直腸癌
    　4 胆道癌
    　5 肛門癌
    　6 直腸・肛門癌リンパ節領域 CTVアトラス

    Chapter 5　泌尿器・男性生殖器
    　1 膀胱癌
    　2 前立腺癌根治照射
    　3 前立腺全摘除術後の放射線治療
    　4 前立腺癌 ─高線量率組織内照射─
    　5 前立腺癌 ─密封小線源永久挿入療法─
    　6 前立腺 CTVアトラス
    　7 精巣(睾丸)腫瘍
    　8 陰茎癌

    Chapter 6　婦人科
    　1 子宮頸癌
    　2 子宮体癌
    　3 膣癌・外陰癌

    Chapter 7　血液・リンパ・皮膚・骨・軟部
    　1 ホジキンリンパ腫
    　2 非ホジキンリンパ腫
    　3 節外性リンパ腫
    　4 骨髄腫
    　5 皮膚癌
    　6 骨・軟部腫瘍
    　7 骨・軟部腫瘍の重粒子線(炭素イオン線)治療

    Chapter 8　小　児
    　1 小児癌
    　2 小児腎腫瘍(ウィルムス腫瘍,その他の腎腫瘍)
    　3 横紋筋肉腫
    　4 神経芽腫
    　5 ユーイング肉腫
    　6 小児白血病
    　7 小児癌の陽子線治療

    Chapter 9　緩　和
    　1 脳転移
    　2 骨転移
    　3 緊急照射(脊髄圧迫)
    　4 緊急照射(上大静脈症候群)

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

Chapter 1 中枢神経系

P.15 掲載の参考文献
1) Walker MD, Alexander E Jr, Hunt WE, et al. : Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49 : 333-343, 1978
PubMed
2) Andersen AP. : Postoperative irradiation of glioblastomas. Results in a randomized series. Acta Radiol Oncol Radiat Phys Biol 17 : 475-484, 1978
 
3) Chin HW, Young AB, Maruyama Y. : Survival response of malignant gliomas to radiotherapy with or without BCNU or methyl-CCNU chemotherapy at the University of Kentucky Medical Center. Cancer Treat Rep 65 : 45-51, 1981
 
4) Kristiansen K, Hagen S, Kollevold T, et al. : Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time : a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47 : 649-652, 1981
 
5) Stewart LA. : Chemotherapy in adult high-grade glioma : a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359 : 1011-1018, 2002
PubMed
6) Stupp R, Mason WP, van den Bent MJ, et al. : Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 : 987-996, 2005
PubMed
7) Stupp R, Hegi ME, Mason WP, et al. : Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study : 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10 : 459-466, 2009
 
8) 日本放射線腫瘍学会監修 : 放射線治療計画ガイドライン 2016年版 第4版, 金原出版, 57-59, 2016
 
9) 井上俊彦, 他 : がん放射線治療と看護の実践, 金原出版, 2011
 
P.18 掲載の参考文献
1) 澁谷均, 晴山雅人, 平岡眞寛 : エビデンス放射線治療, 中外医学者, 2007
 
2) van den Bent M. J., Afra D., de Witte O., et al. : Long-term efficacy of early versus delayed radiotherapy for lowgrade astrocytoma and oligodendroglioma in adults : the EORTC 22845 randomized trial. Lancet 366 : 985-990, 2005
PubMed
3) Karim A. B., Afra D., Cornu P., et al. : Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult : European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BR04 : an interim analysis. Int J Radiat Oncol Biol Phys 52 : 316-324, 2002
 
4) 日本放射線腫瘍学会, 監修 : 放射線治療計画ガイドライン 2016年版 第4版, 金原出版, 60-63, 2016
 
P.23 掲載の参考文献
1) Oyharcabel-Bourden V, Kalifa C, Genter JC, et al. : Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy : a French Society of Pediatric Oncology Group Study. J Clin Oncol 23 : 4726-4734, 2005
 
2) Packer RJ, Gajjar A, Vezina G, et al. : Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 24 : 4202-4208, 2006
PubMed
3) Thomas PR, Deutsch M, Kepner JL, et al. : Low-stage medulloblastoma : final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol 18 : 3004-3011, 2000.
PubMed
4) Bailey CC, Gnekow A, Wellek S, et al. : Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO) : SIOP II. Med Pediatr Oncol 25 : 166-178, 1995
PubMed
5) 日本放射線腫瘍学会監修 : 放射線治療計画ガイドライン 2016年版 第4版, 金原出版, 64-67, 2016
 
P.27 掲載の参考文献
1) Balmaceda C, Heller G, Rosenbulum M, et al. : Chemotherapy without irradiation-a novel approach for newly diagnosed CNS germ cell tumors : results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. J Clin Oncol 14 : 2908-2915, 1996
 
2) Aoyama H, Shirato H, Kakuto Y, et al. : Pathologically-proven intracranial germinoma treated with radiation therapy. Radiother Oncol 47 : 201-205, 1998
PubMed
3) Calaminus G, et al. : SIOP CNS GCT 96 : final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro Oncol 15 : 788-96, 2013
PubMed
4) Rogers SJ, Mosleh-Shirazi MA, Saran FH. : Radiotherapy of localized intracranial germinoma : time to sever historical ties? Lancet Oncol 6 : 509-519 : 2005
PubMed
5) 久米恵江, 他 : がん放射線療法ケアガイド新訂版, 中山書店, 2013
 
P.30 掲載の参考文献
1) McLaughlin MP, Marcus RB Jr, Buatti JM, et al. : Ependymoma : Results, prognostic factors and treatment recommendations. Int J Radiat Oncol Biol Phys 40 : 845-850, 1998
PubMed
2) Oya N, Shibamoto Y, Nagata Y, et al. : Postoperative radiotherapy for intracranial ependymoma : analysis of prognostic factors and patterns of failure. J Neurooncol 56 : 87-94, 2002
PubMed
3) Merchant TE, Li C, Xiong X, et al. : Conformal radiotherapy after surgery for paediatric ependymoma : a prospective study. Lancet Oncol 10 : 258-266, 2009
PubMed
4) 日本放射線腫瘍学会監修 : 放射線治療計画ガイドライン 2016年版 第4版, 金原出版, 68-69, 2016
 
5) 井上俊彦, 他 : がん放射線治療と看護の実践, 金原出版, 2011
 
6) 久米恵江, 他 : がん放射線療法ケアガイド新訂版, 中山書店, 2013
 
P.34 掲載の参考文献
1) ganjoho. jp 国立がん研究センターがん情報サービス
 
2) Kobayashi T. : Long-term results of stereotactic gamma knife radiosurgery for pituitary adenomas. Specific strategies for different types of adenoma. Prog Neurol Surg 22 : 77-95, 2009
PubMed
3) Pollock BE : Radiosurgery for pituitary adenomas. Prog Neurol Surg 20 : 164-171, 2007
PubMed
4) Rush S, Cooper PR. : Symptom resolution, tumor control, and side effects following postoperative radiotherapy for pituitary radiotherapy for pituitary macroadenomas. Int J Radiat Oncol Biol Phys 37 : 1031-1034, 1997
PubMed
5) Iwata H, Sato K, Tatewaki K, et al. : Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma : high local control with low toxicity. Neuro Oncol 13 : 916-922, 2011
PubMed
6) 日本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016年版, 金原出版, 2016
 
7) Sheehan Jp, Niranjan A, Sheehan JM, et al. : Stereotactic radiosurgery for pituitary adenomas : an intermediate review of its safety, efncacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 102 : 678-691, 2005
PubMed
8) Littley MD, Shalet SM, Beardwell CG, et al. : Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med 262 : 145-160, 1989
PubMed
9) 井上俊彦, 他 : がん放射線治療と看護の実践, 金原出版, 2011
 
10) 久米恵江, 他 : がん放射線療法ケアガイド新訂版, 中山書店, 2013
 
P.37 掲載の参考文献
1) Andrews DW, Suarez O, Goldman HW, et al. : Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas : comparative observations of 125 patients treated at one institution. Int J Radiat Oncol Biol Phys 50 : 1265-1278, 2001
PubMed
2) Sakanaka K, Mizowaki T, Arakawa Y, et al. : Hypofractionated stereotactic radiotherapy for acoustic neuromas : safety and effectiveness over 8 years of experience. Int J Clin Oncol 16 : 27-32, 2011
PubMed
3) Hasegawa T, Kida Y, Kobayashi T, et al. : Long-term outcomes in patients with vestibular schwannomas treated using gamma knife surgery : 10-year follow up. J Neurosurg 102 : 10-16, 2005
PubMed
4) Koh ES, Millar BA, Menard C, et al. : Fractionated stereotactic radiotherapy for acoustic neuroma : single-institution experience at The Princess Margaret Hospital. Cancer 109 : 1203-1210, 2007
PubMed
5) 日本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016年版, 金原出版, 2016
 
P.42 掲載の参考文献
1) Osborn AG : Diagnostic Neuroradiography, Mosby, St. Louis. 1994
 
2) Louis DN, Ohgaki H, Wiestler OD, et al. : ed. WHO Classification of Tumors of the Central Nervous System, 4th ed. WHO/IARC Classification of Tumors, Vol. 1. Geneva, The World Health Organization, 2007
 
3) Oya S, Kim SH, Sade B, et al. : The natural history of intracranial meningiomas, J Neurosurg 114 : 1250-1256, 2011
PubMed
4) Maclean J, Fersht N, Short S. Controversies in radiotheraphy for meningioma. Clin Oncol 26 : 51-64, 2014
 
5) Goyal N, Kakkar A, Sarkar C, et al. : Does bony hyperostosis in intracranial meningioma signify tumor invasion? Aradiopathologic study. Neurol India 60 : 50-54, 2012
PubMed
6) Qi ST, Liu Y, Pan J, et al. : A radiopathological classification of dural tail sign of meningioma. J Neurosurg 117 : 645-653, 2012
 
7) Morimoto M, Yoshioka Y, Shiomi H, et al. : Significance of tumor volume related to peritumoral edema in intracranial meningioma treated with extreme hypofranctionated stereotactic radiation theraphy in three of five fractions. Jpn J Clin Oncol 41 : 609-616, 2011
 
8) Tanzler E, Morris CG, Kirwan JM, et al. : outcomes of WHO grade I meningiomas receiving definitive or postoperative radiotheraphy. Int J Radiat Oncol Biol Phys 79 : 508-513, 2011
 
9) Santacroce A, Walier M, Regis J, et al. : Long-term tumor control of benign intracranial meningiomas after radiosurgery in a series of 4565 patients. Neurosurgery 70 : 32-39, 2011
 
10) Kaul D, Budach V, Wurm R, et al. : Linac-based stereotactic radiotheraphy and radiosurgery in patients with meningioma. Radiat Oncol 9 : 78-86, 2014
 
11) Conti A, Pontoriero A, Midili F, et al. : Cypherknife multisession stereotactic radiosurgery and hypofractionated stereotactic radiotheraphy for perioptic meningiomas : intermediate-term results and radiobiological considerations. Springerplus 4 : 37-44, 2015
 
12) Bloch O, Kaur G, Jain BJ, et al. : Stereotactic radiosurgery for benign menigiomas. J Neurooncol 107 : 13-20, 2012
 
13) Hasan S, Young M, Albert T, et al. : The role of adijuvant radiotheraphy after gross total resection of atypical menigiomas. World Neurosurg 83 : 808-815, 2015
 
14) Cai R, Barnett GH, Novak E, et al. : Principal risk of peritumoral edema after stereotactic radiosurgery for intracranial meningioma is tumor-brain contact interface area. Neurosurg 66 : 513-522, 2010
 
15) 井上俊彦, 他 : がん放射線治療と看護の実践, 金原出版, 2011
 
16) 久米恵江, 他 : がん放射線療法ケアガイド新訂版, 中山書店, 2013
 
P.46 掲載の参考文献
1) Abdel-Wahab M, Etuk B, Palermo J, et al. : Spinal cord gliomas : A multi-institutional retrospective analysis. Int J Radi at Oncol Biol Phys. 64 : 1060-1071, 2006
 
2) Modha A, Gutin PH. : Radical excision of intramedullary spinal cord tumors : surgical morbidity and longterm follow-up evaluation in 164 children and young adults. J Neurosurg 93 (2 Suppl) : 183-93, 2000
 
3) 久米恵江, 他 : がん放射線療法ケアガイド新訂版, 中山書店, 2013
 

Chapter 2 頭頸部

P.50 掲載の参考文献
1) 日本放射線腫瘍学会監修 : 放射線治療計画ガイドライン 2016年版, 金原出版, 2016
 
2) Reisner ML, PaisVi6gas CM, Grazziotin RZ, et al. : Retinoblastoma-comparative analysis of external radiotherapy techniques, including an IMRT technique. Int J Radiat Oncol Biol Phys. 67 : 933-41, 2007
 
3) Shields CL, Mashayekhi A, Au AK, et al. : The International Classification of Retinoblastoma Predicts Chemoreduction Success. Ophthalmology 113 : 2276-2280, 2006
PubMed
4) Wiegel T, Bottke D, Kreusel KM, et al. : External beam radiotherapy of choroidal metastases final results of a prospective study of the German Cancer Society (ARO 9508). Radiother Oncol 64 : 1318, 2002
 
5) 日本看護協会出版会 : 頭頸部がんの化学放射線療法, 56, 2015
 
P.54 掲載の参考文献
1) 日本放射線腫瘍学会監修 : 放射線治療計画ガイドライン 2016年版, 金原出版, 2016
 
2) Kang JH, Cho SH, Pyeong-Kim J, Kang KM, Cho KS, Kim W, Mi-Seol Y, Lee S, Soo-Park H, Joo-Hur W, Choi YJ, Oh SY. : Treatment outcomes between concurrent chemoradiotherapy and combination of surgery, radiotherapy, and/or chemotherapy in stage III and IV maxillary sinus cancer : multi-institutional retrospective analysis. J Oral Maxillofac Surg. 70 : 1717-1723, 2012
PubMed
3) Jang NY, Wu HG, Park CI, Heo DS, Kim DW, Lee SH, Rhee CS. : Definitive radiotherapy with or without chemotherapy for T3-4N0 squamous cell carcinoma of the maxillary sinus and nasal cavity. Jpn J Clin Oncol. 40 : 542-548, 2010
PubMed
4) Homma A, Sakashita T, et al : Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer. Br J Cancer 109 : 2980-2986, 2013
PubMed
5) 日本看護協会出版会 : 頭頸部がんの化学放射線療法, 2015
 
P.60 掲載の参考文献
1) 日本口腔外科科学会 : 科学的根拠に基づく口腔癌診療ガイドライン, 2013年版
 
2) Petti, S. Scully, C. : Oral cancer : the association between nation-based alcohol-drinking profiles and oral cancer mortality. Oral Oncol 41 : 828-834, 2005
PubMed
3) Sankaranarayanan, R., Ramadas, K., et al. : Effect of screening on oral cancer mortality in Kerala, India : a cluster-randomised controlled trial. Lancet 365 : 1927-1933, 2005
PubMed
4) Fuwa, N., Kodaira, T., et al. : Intra-arterial chemoradiotherapy for locally advanced oral cavity cancer, analysis of therapeutic results in 134 cases. Br J Cancer 98 : 1039-1045, 2008
PubMed
5) 日本放射線腫瘍学会監修 : 放射線治療計画ガイドライン 2016年版, 金原出版, 2016
 
6) Inoue T, Inoue T, Yamazaki H, et al. : High dose rate versus low dose rate interstitial radiotherapy for carcinoma of the floor of mouth. Int J Radiat Oncol Biol Phys 41 : 53-58, 1998
PubMed
7) Matsumoto S, Takeda M, Shibuya H, et al. : T1 and T2 squamous cell carcinomas of the floor of the mouth : results of brachytherapy mainly using 198Au grains. Int J Radiat Oncol Biol Phys 34 : 833-841, 1996
PubMed
8) Wang CC. : Radiation therapy for head and neck neoplasms : Indications, techniques and results. Littleton, MA, Wright-PSG, 1983
 
9) Shibuya H, Horiuchi J, Suzuki S, et al. : Oral carcinoma of the upper jaw : Results of radiation treatment. Acta Radiol Oncol 23 : 331-335, 1984
PubMed
10) 日本看護協会出版会 : 頭頸部がんの化学放射線療法, 56, 2015
 
P.66 掲載の参考文献
1) MW McDonald, J Lawson, MK Garg, et al. : ACR appropriateness criteria retreatment of recurrent head and neck cancer... expert panel on radiation oncology : Head and neck cancer Int J Radiat Oncol Biol Phys 80 : 1292-1298, 2011
 
2) Marta GN, et al. : Intensity-modulated radiation therapy for head and neck cancer : systematic review and meta-analysis. Radiother Oncol. 110 : 9-15, 2014
PubMed
3) Kawashima M, Fuwa N, Myojin M, et al. : A multi-institutional survey of the effectiveness of chemotherapy combined with radiotherapy for patients with nasopharyngeal carcinoma. Jpn J Clin Oncol 34 : 569-583, 2004
PubMed
4) 日本看護協会出版会 : 頭頸部がんの化学放射線療法, 56, 2015
 
P.71 掲載の参考文献
1) Adelstein DJ, Li Y, Adams GL, et al. : An intergroup phase III comparison of standared radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21 : 92-98, 2003
 
2) Izuno I, Sone S, Oguchi M, et al. : Treatment of early vocal cord carcinoma with 60 Co gamma rays, 8/10 MV xrays, or 4 MV x-rays are the results different? Acta Oncol 29 : 637-639, 1990
PubMed
3) Akine Y, Tokita N, Ogino T, et al. : Radiotherapy of T1 glottic cancer with 6 MeV X rays. Int J Radiat Oncol Biol Phys 20 : 1215-1218, 1991
PubMed
4) 日本放射線腫瘍学会監修 : 放射線治療計画ガイドライン 2016年版, 金原出版, 2016
 
5) 日本看護協会出版会 : 頭頸部がんの化学放射線療法, 2015
 
P.76 掲載の参考文献
1) 井上俊彦, 他 : 放射線治療学 改訂5版, 南山堂, 2014
 
2) 日本放射線腫瘍学会監修 : 放射線治療計画ガイドライン 2016年版, 金原出版, 2016
 
3) Nakamura K, Shioyama Y, Kawashima M, et al. : Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 65 : 1045-1050, 2006
PubMed
4) 日本看護協会出版会 : 頭頸部がんの化学放射線療法, 56, 2015
 
P.82 掲載の参考文献
1) Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, et al : American society of clinical oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24 : 3693-3704, 2006
 
2) Izuno I, Sone S, Oguchi M, et al. : Treatment of early vocal cord carcinoma with 60Co gamma rays, 8/10 MV xrays, or 4 MV x-rays are the results different? Acta Oncol 29 : 637-639, 1990
PubMed
3) 日本放射線腫瘍学会, 監修 : 放射線治療計画ガイドライン 2016年版, 金原出版, 2016
 
4) Akine Y, Tokita N, Ogino T, et al. : Radiotherapy of T1 glottic cancer with 6 MeV X rays. Int J Radiat Oncol Biol Phys 20 : 1215-1218, 1991
PubMed
5) Mendenhall WM, et al : Larynx, (in) Halperin EC et al eds : Perez and Brady's Principles and Practice of Radiation Oncology, Lippincott : 975-995, 2007
 
6) 日本看護協会出版会 : 頭頸部がんの化学放射線療法, 56, 2015
 
P.86 掲載の参考文献
1) 日本放射線腫瘍学会, 監修 : 放射線治療計画ガイドライン 2016年版, 金原出版, 2016
 
2) Garden AS, eL-Naggar AK, Morrison WH, et al. : Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys 37 : 79-85, 1997
PubMed
3) Terhaard CH, Lubsen H, Rasch CR, et al. : The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys 61 : 103-111, 2005
PubMed
4) Chen AM, Bucci MK, Quivey JM, et al. : Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas. Int J Radiat Oncol Biol Phys 66 : 1044-1050, 2006
PubMed
5) 日本看護協会出版会 : 頭頸部がんの化学放射線療法, 56, 2015
 
P.91 掲載の参考文献
1) Shibuya H, Hoshina M, Takeda M, et al. : Brachytherapy for stage I & II oral tongue cancer : an analysis of past cases focusing on control and complications. Int J Radiat Oncol Biol Phys 26 : 51-58, 1993
 
2) Fujita M, Hirokawa Y, Kashiwado K, et al. : Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue : factors influencing local control and soft tissue complications. Int J Radiat Oncol Biol Phys 44 : 767-775, 1999
 
3) 日本看護協会出版会 : 頭頸部がんの化学放射線療法, 2015
 

Chapter 3 胸部

P.98 掲載の参考文献
1) 日本肺癌学会編 : EBMの手法による肺癌診療ガイドライン 2014年版, 金原出版, 2014
 
2) Atagi S, Kawahara M, Yokoyama A, et al. : Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell Iung cancer : a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301). Lancet Oncol. 13 (7) : 671-8, 2012
 
3) Giraud P, Antoine M, Larrouy A, et al. : Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 59 : 1015-1024, 2000
 
4) Bradley JD, Paulus R, Komaki R, et al. : A randomized phase III comparison of standard-dose (60Gy) versus high-dose (74Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer. Results on radiation dose in RTOG 0617. J Clin Oncol. 31 (suppl : abstr 7501). (II), 2013
 
5) Tsujino K, Hirota S, Endo M, et al. : Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 55 : 110-115, 2003
 
6) Kiura K, Takigawa N, Segawa Y, et al. : Randomized phase III trial of docetaxel and cisplatin combination chemotherapy versus mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer : OLCSG 0007, J Clin Oncol 26 : 7515, 2008
 
7) Satouchi M, Yamamoto N, Chiba Y, et al. : Randomized phase III study of mitomycin/vindesine/cisplatin (MVP) versus weekly irinotecan/carboplatin (IC) or weekly paclitaxel/carboplatin (PC) with concurrent thoracic radiotherapy (TRT) for unresectable stage III non-small cell lung cancer (NSCLC) : WJTOG0105, J Clin Oncol 27 : 7504, 2009
 
8) 唐澤久美子, 編 : がん放射線治療の理解とケア, Nursing Mook 43, 学習研究社, 2007
 
9) 菱川良夫, 監修 : 看護の力でQOLを向上させる! 放射線治療を受けるがん患者の看護ケア, 日本看護協会出版会, 2008
 
P.102 掲載の参考文献
1) 日本肺癌学会, 編 : EBMの手法による肺癌診療ガイドライン 2014年版, 金原出版, 2014
 
2) Tsuchiya R, Suzuki K, Ichinose Y, et al. : Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer : the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). JThorac Cardiovasc Surg 129. 977-983, (III), 2005
 
3) Pignon JP, Arriagada R, Ihde DC, et al. : A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327. 1618-1624, (1), 1992
PubMed
4) Warde P, Payne D. : Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10. 890-895, (I), 1992
PubMed
5) Takada M, Fukuoka M, Kawahara M, et al. : Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer : results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 20. 3054-3560, (II), 2002
 
6) Turrisi AT 3rd, Kim K, Blum R, et al. : Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340. 265-271, (II), 1999
 
7) Auperin A, Arriagada R, Pignon Jp, et al. : Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 341. 476-484, (I), 1999
 
8) Le P6choux C, Dunant A, Senan S, et al : Prophylactic Cranial Irradiation (PCI) Collaborative Group. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01) : a randomised clinical trial. Lancet Oncol 10. 467-474, (II), 2009
 
9) 唐澤久美子, 編 : がん放射線治療の理解とケア, Nursing Mook 43, 学習研究社, 2007
 
10) 菱川良夫, 監修 : 看護の力でQOLを向上させる! 放射線治療を受けるがん患者の看護ケア, 日本看護協会出版会, 2008
 
P.107 掲載の参考文献
1) Onishi H, Kuriyama K, Komiyama T, et al : A new irradiation system for lung cancer combining linear accelerator, computed tomography, patient self-breath-holding, and patient-directed beam-control without respiratory monitoring devices, Medical Physics, 56 (1), 14-20, 2003
 
2) Negoro Y. Nagata Y. Aoki T et al. : The effectiveness of an imrnobolization device in conformal radiotherapy for lung tumor : reduction of respiratory tumor mov e ment and evaluation of the daily set-up accuracy. Int. J. Radiat Oncol Biol Phys 50 : 889-898, 2001
 
3) Shirato H, Shimizu S, Shimizu T, et al. : Real-time tumor-tracking radiotherapy. Lancet 353 : 1331-1332, 1999
PubMed
4) Nagata Y, Hiraoka M, Shibata T, et al. : A Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer : Japan Clinical Oncology Group Study JCOG0403. Int J Radiat Oncol Biol Phys 93 (5) : 989-96, 2015
 
5) Timmerman R, Papiez L, McGarry R, et al. : Extracranial stereotactic radioablation : results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124 : 1946-55, 2003
 
6) Wulf J, Haedinger U, Oppitz U, et al. : Stereotactic radiotherapy for primary lung cancer and pulmonary metastases : a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 60. 186-96, 2004
PubMed
7) 輿石強太, 青木真一, 南部敦史, 他 : 肺定位放射線治療後の肋骨骨折について. 山梨肺癌研究会会誌 23 : 15-18, 2010
 
8) Kimura T, Nagata Y, Eba J, et al. : A randomized Phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable Stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer : Japan Clinical Oncology Group Study JCOG1408 (J-SBRT trial). Japanese Journal of Clinical Oncol 47, 277-281, 2017
PubMed
P.112 掲載の参考文献
1) 大西洋, 唐澤克之, 唐澤久美子, 編 : がん・放射線療法 2010, 篠原出版新社, 805-811, 2010
 
2) 近藤薫, 山川洋右, 正岡昭, 他 : 胸腺癌19例の臨床的検討, 日胸外科会誌 44 : 169-174, 1996
 
3) Rena O, Papalia E, Oliaro A, et al. : Does adjuvant radiation therapy improve disease-free survival in completely resected Masaoka stage II thymoma? Eur J Cardiothorac Surg 31 : 109-113, 2007
PubMed
4) Ogawa K, Uno T, Toita T, et al. : Postoperative radiotherapy for patients with completely resected thymoma : a multi-institutional, retrospective review of 103 patients. Cancer 94 : 1405-1413, 2002
PubMed
5) Kondo K, Monden Y. : Therapy for thymic epithelial tumors : a clinical study of 1,320 patients from Japan. Ann Thorac Surg 76. 878-884, 2003
PubMed
6) Ogawa K, Toita T, Uno T, et al. : Treatment and prognosis of thymic carcinoma : a retrospective analysis of 40 cases. Cancer 94 : 3115-3119, 2002
PubMed
7) 唐澤久美子, 編 : がん放射線治療の理解とケア, Nursing Mook 43, 学習研究社, 2007
 
8) 菱川良夫, 監修 : 看護の力でQOLを向上させる! 放射線治療を受けるがん患者の看護ケア, 日本看護協会出版会, 2008
 
P.116 掲載の参考文献
1) EBCTCG : Early Breast Cancer Trialists' Collaborative Group, Darby S. et al. : Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death : meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet, 378, 1707-1716, 2011
 
2) 坂元吾偉, 芳賀駿介, 監修 : 非浸潤性乳管癌の基礎と臨床, 篠原出版新社, 42, 2001
 
3) Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolmark N. : Prevention of invasive breast cancer in women with ductal carcinoma in situ : an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol. 28 (4) : 400-418, 2001
PubMed
4) Bijker N, Meijnen P, Peterse JL, et al. : Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ : ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol. 24 (21) : 3381-3387, 2006
PubMed
5) Houghton J, George WD, Cuzick J, Duggan C, Fentiman IS, Spittle M. : UK Coordinating Committee on Cancer Research : Ductal Carcinoma in situ Working Party : DCIS trialists in the UK, Australia, and New Zealand. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand : randomised controlled trial. Lancet. : 362 (9378) : 95-102, 2003
PubMed
6) 日本乳癌学会, 編 : 科学的根拠に基づく乳癌診療ガイドライン, 2015年版, 2015
 
7) Johansen J. et al. : Treatment morbidity associated with the management of the axilla in breast-conserving therapy. Acta Oncologica 39 : 349-354, 2000
PubMed
8) Recht A et al. : Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol. Jun : 9 (6) : 988-96, 1991
PubMed
9) Bartelink, H, Horiot, JC, Poortmans, PM et al. : Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer : 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol. 25 : 3259-3265, 2007
 
10) Smith BD, Bentzen SM, Correa CR, et al, : Fractionation for Whole Breast Irradiation : An American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline. Int J Radiation Oncology Biol Phys. : 81 (1) : 59-68, 2011
 
11) Clarke M, Collins R, Darby S, et al, : Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival : an overview of the randomised trials. Lancet. : 366 (9503) : 2087-2106, 2005
PubMed
12) 唐澤久美子, 編 : がん放射線治療の理解とケア, Nursing Mook 43, 学習研究社, 2007
 
13) 菱川良夫, 監修 : 看護の力でQOLを向上させる! 放射線治療を受けるがん患者の看護ケア, 日本看護協会出版会, 2008
 
P.121 掲載の参考文献
1) Clarke M, Collins R, Darby S, et al. : Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and l5-year survival : an overview of the randomised trials. Lancet. : 366 (9503) : 2087-2106, 2005
 
2) McGale P, Taylor C, Correa C, et al. : for the Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality : meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 383 (9935) : 2127-35, 2014
 
3) Hennequin C, Bossard N, Servagi-Vernat S, et al. : Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy. Int J Radiat Oncol Biol Phys. : 86 : 860-6, 2013
PubMed
4) Pierce LJ, Butler JB, Martel MK, Normolle DP, Koelling T, Marsh RB, et al. : Postmastectomy radiotherapy of the chest wall : dosimetric comparison of common techniques. Int J Radiat Oncol Biol Phys : 52 : 1220-30, 2002
PubMed
5) Metz JM, Schultz DJ, Fox K, et al. : Analysis of outcomes for high-risk breast cancer based on interval from surgery to postmastectomy radiation therapy. Cancer J. : 6 : 324-330, 2000
PubMed
6) 唐澤久美子, 編 : がん放射線治療の理解とケア, Nursing Mook 43, 学習研究社, 2007
 
7) 菱川良夫, 監修 : 看護の力でQOLを向上させる! 放射線治療を受けるがん患者の看護ケア, 日本看護協会出版会, 2008
 

Chapter 4 消化器

P.128 掲載の参考文献
1) Mizowaki T., et al : Optimal size criteria of malignant lymph nodes in the treatment planning of radiotherapy for esophageal cancer : evaluation by computed tomography and magnetic resonance imaging. Int J Radiat Oncol Biol Phys 36 (5) : 1091-8, 1996
PubMed
2) van Westreenen H. L, et al : Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 22 (18) : 3805-12, 2004
PubMed
3) Gao XS, et al : Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma. Int J Radiat Oncol Biol Phys. : 67 (2) : 389-96, 2007
PubMed
4) Yaremko BP, et al : Determination of respiratory motion for distal esophagus cancer using four-dimensional computed tomography. Int J Radiat Oncol Biol Phys. : 70 (1) : 145-53, 2008
PubMed
5) 日本放射線腫瘍学会監修 : 放射線治療計画ガイドライン 2016年版, 金原出版, 2016
 
6) Kato H, Sato A, Fukuda H., et al : A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma : Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol 39 : 638-643, 2009
 
7) Kato K., Muro K., Minashi K., et al : Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma : JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys 81 : 684-690, 2011
PubMed
8) 日本看護協会出版会 : 頭頸部がんの化学放射線療法, 日本看護協会出版, 50, 56, 2015
 
P.134 掲載の参考文献
1) 日本放射線腫瘍学会監修 : 放射線治療計画ガイドライン 2016年版, 金原出版, 2016
 
2) Bosset JF, Collette L, Calais G, et al : EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355 : 1114-1123, 2006
PubMed
3) Gerard JP, Conroy T, Bonnetain F, et al. : Preoperative radiotherapy with or without concurrent fiuorouracil and leucovorin in T3-4 rectal cancers : results of FFCD 9203. J Clin Oncol 24 : 4620-4625, 2006
 
4) Nagawa H, Muto T, Sunouchi K, et al. : Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 44 : 1274-1280, 2001
PubMed
P.137 掲載の参考文献
1) 日本放射線腫瘍学会監修 : 放射線治療計画ガイドライン 2016年版, 金原出版, 2016
 
2) Shinohara ET, Mitra N, Guo M, Metz JM. : Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 72 (5) : 1495-1501, 2008
PubMed
3) Shinohara ET, Mitra N, Guo M, et al. : Radiation therapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas. Int J Radiat Oncol Biol Phys 74 : 1191-1198, 2009
PubMed
P.140 掲載の参考文献
1) Boman BM, Moertel CG, O'Connell MJ, et al. : Carcinoma of the anal canal : A clinical and pathologic study of 188 cases. Cancer 54 : 114-125, 1984
PubMed
2) 日本放射線腫瘍学会監修 : 放射線治療計画ガイドライン 2016年版, 金原出版, 2016
 
3) Okamoto M, Karasawa K, Ito Y, et al. : Radiotherapy for anal cancer in Japan : A retrospective multiinstitutional study. Int J Radiat Oncol Biol Phys 66 : S311, 2006
 

Chapter 5 泌尿器離・男性生殖器

P.146 掲載の参考文献
1) Eric K. Hansen : Handbook of Evidence-based Radiation Oncology, 2010
 
2) El本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016, 金原出版, 東京, 217-221, 2016
 
3) 澁谷均, 他編著 : エビデンス放射線治療, 中外医学社, 388-392, 2007
 
4) Rodel C, Grabenbauer GG, Kuhn R, Papadopoulos T, Dunst J, Meyer M, Schrott KM, Sauer R. Combined-modality treatment and selective organ preservation in invasive bladder cancer : long-term results. J Clin Oncol 20 : 3061-3071, 2002
PubMed
P.150 掲載の参考文献
1) 日本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016, 金原出版, 東京, 222-225, 2016
 
2) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines(R)) Prostate Cancer Version 3. 2016
 
3) Boehmer D, Maingon P, Poortmans P, et al. : Guidelines for primary radiotherapy of patients with prostate cancer. Radiother Oncol 79 : 259-269, 2006
PubMed
4) 大西洋, 他, 編著 : がん・放射線療法 2017, 秀潤社, 971-976, 2017
 
5) Kupelian PA et al : Int J Radiat Oncol Biol Phys 58 : 25-33, 2004
PubMed
6) BJU Int. 2012 Feb : 109 Suppl 1 : 22-9. doi : 10.1111/j.1464-410X.2011.10827.x. Grimm P, Billiet I, Bostwick D, et al. : Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int 109 : 22-29, 2012
 
P.153 掲載の参考文献
1) 大西洋, 他, 編著 : がん・放射線療法 2017, 秀潤社, 977-983, 2017
 
2) 日本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016. 金原出版, 東京, 226-228, 2016
 
3) Aoki M, Mizowaki T, Akimoto T, et al. : Adjuvant radiotherapy after prostatectomy for prostate cancer in Japan : a multi-institutional survey study of the JROSG. J Radiat Res 55 : 533-540, 2014
PubMed
4) Mizowaki T, Aoki M, Nakamura K, et al. : Current status and outcomes of patients developing PSA recurrence after prostatectomy who were treated with salvage radiotherapy : a JROSG surveillance study. J Radiat Res 56 : 750-756, 2015
PubMed
P.157 掲載の参考文献
1) 日本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016. 金原出版, 東京, 229-233, 2016
 
2) 大西洋, 他, 編著 : がん・放射線療法 2017, 秀潤社, 964-970, 2017
 
3) Yamada Y, Rogers L, Demanes DJ, et al. : American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy. Brachytherapy 11 : 20-32, 2012
PubMed
4) Hoskin PJ, Colombo A, Henry A, et al. : GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer : an update. Radiother Oncol 107 : 325-332, 2013
PubMed
5) Hsu IC, Yamada Y, Assimos DG, et al. : ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer. Brachytherapy 13 : 27-31, 2014
PubMed
6) Brakati M, et al : Int J Radiat Oncol Biol Phys 82 : 1889-1896, 2012
 
7) Demanes DJ, et al : Int J Radiat Oncol Biol Phys 81 : 1286-1292, 2011
PubMed
8) Martinez AA, et al : Am J clin Oncol 33 : 481-488, 2010
PubMed
P.160 掲載の参考文献
1) 日本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016. 金原出版, 東京, 234-238, 2016
 
2) NCCN Clinical : Practice Guidelines in Oncology (NCCN Guidelines(R)) Prostate Cancer Version 3. 2016
 
3) 大西洋, 他, 編著 : がん・放射線療法 2017, 秀潤社, 964-970, 2017
 
4) 大西洋, 他, 編著 : がん・放射線療法 2010, 篠原出版, 435-437, 2010
 
5) Grimm P, Billiet I, Bostwick D, et al. : Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int 109 : 22-29, 2012
 
P.162 掲載の参考文献
1) 日本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016. 金原出版, 東京, 239-243, 2016
 
2) Boehmer D, Maingon P, Poortmans P, et al. : Guidelines for primary radiotherapy of patients with prostate cancer. Radiother Oncol 79 : 259-269, 2006
PubMed
P.166 掲載の参考文献
1) 大西洋, 他, 編著 : がん・放射線療法 2017, 秀潤社, 988-992, 2017
 
2) 日本公衆衛生協会 : 平成12年度環境省委託業務課報告書内分泌撹乱化学物質のヒトへの影響調査研究, 49-55 http://www.env.go.jp/chemi/report/h16-05/full.pdf
 
3) Donohue JP et al. : J Urol 128 : 315-320, 1982
PubMed
4) Morton GC et al : Testicular Cancer in Halperin EC. Perez CA et al. : eds Principles and Practice of Radiation Oncology 6th ed. Lippincott Williams & Willkins Philadelphia, 1334-1344, 2013
 
5) Brierley JD et al (eds) : UICC : TNM Classification of Malignant Tumours 8th edition. JOHN WILEY & SONS, LTD., New York, 2017
 
6) 日本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016. 金原出版, 東京, 244-246, 2016
 
7) Classen J et al : J Clin Oncol 21 : 1101-1106, 2003
 
8) Gordon W Jr et al. : Int J Radiat Oncol Biol Phys 38 : 83-94, 1997
PubMed
P.169 掲載の参考文献
1) 大西洋, 他, 編著 : がん・放射線療法 2017, 秀潤社, 993-999, 2017
 
2) Brierley JD et al (eds) : UICC : TNM Classification of Malignant Tumours 8th edition. JOHN WILEY & SONS, LTD., New York, 2017
 
3) Jackson SM : The British journal of surgery 53 : 33-35, 1966
PubMed
4) 日本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016. 金原出版, 東京, 247-250, 2016
 
5) Van Poppel H, Watkin NA, Osanto S, et al. : Penile cancer : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24 : vill5--124, 2013
 
6) Crook JM, Haie-Meder C, Demanes DJ, et al. : American Brachytherapy Society-Groupe Europeen de Curieth6rapie-European Society of Therapeutic Radiation Oncology (ABS-GEC-ESTRO) consensus statement for penile brachytherapy. Brachytherapy 12 : 191-198, 2013
PubMed
7) Pizzocaro G, Algaba F, Horenblas S, et al. : EAU penile cancer guidelines 2009. Eur Urol 2010 : 57 : 1002-1012, 2010
PubMed

Chapter 6 婦人科

P.177 掲載の参考文献
1) 大西洋, 他, 編著 : がん・放射線療法 2017 改定第7版, 学研メディカル周秀潤社, 1002-1015, 2017
 
2) 日本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016. 金原出版, 東京, 251-258, 2016
 
3) Small W et al : Int J Radiat Oncol Biol 71 : 428-434, 2008
 
4) Toita T et al : Int J Ckin Oncol 40 : 456-463, 2010
 
5) Haie-Meder, C, Potter, R., Van Limbergen, E., Briot, E., De Brabandere, M., Dimopoulos, J., et al. : Recommendations from Gynaecological (GYN) GEC ESTRO Working Group (I) : Concepts and Terms in 3D Image Based 3D Treatment Planning in Cervix Cancer Brachytherapy with Emphasis on MRI Assessment of GTV and CTV. Radiotherapy & Oncology, 74, 235-245, 2005
 
6) Potter R, Haie-Meder C, Van Limbergen E, et al. : Recommendations for Gynecological (GYN) GEC ESTRO Working Group (II) : concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D volume parameters and aspects of 3D image-based anatomy, radiation physics radiobiology. Radiother Oncol. 78 : 67-77, 2006
 
7) 日本婦人科腫瘍学会, 編 : 子宮頸癌治療ガイドライン 2011年版, 東京, 金原出版, 2011
 
8) Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer : a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 26 : 5802-5812, 2008
PubMed
P.181 掲載の参考文献
1) 大西洋, 他, 編著 : がん・放射線療法 2017 改定第7版, 学研メディカル周秀潤社, 1016-1024, 2017
 
2) Brierley JD et al. (eds) : UICC : TNM Classification of Malignant Tumours 8th edition. JOHN WILEY & SONS, LTD., New York, 2017
 
3) Pecorelli S et al. : Int J Gynaeclo Obstet 105 : 107-108, 2009
 
4) 日本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016. 金原出版, 東京, 259-263, 2016
 
5) Rustowski J, Kupsc W. : Factors influencing the results of radiotherapy in cases of inoperable endometrial cancer. Gynecol Oncol 14 : 185-193, 1982
PubMed
6) Grigsby PW, Kuske RR, Perez CA, et al. : Medically inoperable stage I adenocarcinoma of the endometrium treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 13 : 483-488, 1987
 
7) Rose PG, Baker S, Kern M, et al. : Primary radiation therapy for endometrial carcinoma : a case controlled study. Int J Radiat Oncol Biol Phys 20 : 585-590, 1993
 
8) Knocke TH, Kucera H, Weidinger B, et al. : Primary treatment of endometrial carcinoma with high-dose-rate brachytherapy : results of 12 years of experience with 280 patients. Int J Radiat Oncol Biol Phys 37 : 359-365, 1997
PubMed
P.184 掲載の参考文献
1) 大西洋, 他, 編著 : がん・放射線療法 2017 改定第7版, 学研メディカル周秀潤社, 1025-1029, 2017
 
2) 日本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016. 金原出版, 東京, 264-268, 2016
 
3) 日本婦人科腫瘍学会編. 外陰がん・膣がん治療ガイドライン 2015年版, 東京, 金原出版, 13-19, 2011
 
4) Pecorelli S : Int J Gynaecol Obstet 105 : 103-104, 2009
PubMed
5) Hiniker SM, Roux A, Murphy JD, et al. : Primary squamous cell carcinoma of the vagina : prognostic factors, treatment patterns, and outcomes. Gynecol Oncol 131 : 380-385, 2013
PubMed
6) Gadducci A, Fabrini MG, Lanfredini N, et al. : Squamous cell carcinoma of the vagina : natural history, treatment modalities and prognostic factors. Crit Rev Oncol Hematol 93 : 211-224, 2015
PubMed
7) Cardenes HR, Schilder JM, Roth LM. Vagina. Barakat RR, Markman M, Randall ME, eds. : Principles and Practice of Gynecologic Oncology (5 th Edition). Philadelphia. Lippincott Williams & Wilkins, 591-622, 2009
 
8) Ansink A, van der Velden J. : Surgical interventions for early squamous cell carcinoma of the vulva. Cochrane Database Syst Rev. (2) : CD0020362000
PubMed
9) Burke TW, Eifel PJ, McGuire WP, et al. : Vulva. Hoskins WJ, Perez CA, Young RC, eds. Principles and Practice of Gynecologic Oncology (3rd edition). Philadelphia, Lippincott Williams & wilkins, 775-810, 2000
 

Chapter 7 血液・リンパ・皮膚・骨・軟部

P.193 掲載の参考文献
1) 日本血液学会 : 造血器腫瘍診療ガイドライン 2013年版. 金原出版, 2013
 
2) Girinsky T, van der Maazen R, Specht L, et al. : Involved-node radiotherapy (INRT) in patients with early Hodglin lymphoma : Concepts and guidelines. Radiother Oncol 79 : 270-277, 2006
PubMed
3) Specht L, Yahalom J, Illidge T, et al. : Modern radiation therapy for Hodgkin lymphoma : Field and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys 89 : 854-862, 2014
PubMed
4) 日本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016年版, 金原出版, 275-280, 2016
 
5) Hasenclever D, Diehl V. : A prognostic sore for advanced Hodgkin's disease. N Eng J Med 339 : 1506-1514, 1998
 
6) 井上俊彦, 他 : がん放射線治療と看護の実践, 金原出版, 2011
 
7) 久米恵江, 他 : がん放射線療法ケアガイド新訂版, 中山書店, 2013
 
P.200 掲載の参考文献
1) Swerdlow SH, Campo E, Harris NL, et al. : Pathology and genetics of tumors of haematolopoetic and lymphoid tissue. WHO Classification of Tumours of Haematopoietic and Land Lmphoid Tissues (4th edition). WHO/IARC Classification of Tumours, Vol. 2. Geneva, The World Health Organization, 2008
 
2) Illidge T, Specht L, Yahalom J, et al : International Lymphoma Radiation Oncology Group. Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 89 : 49-58, 2014
PubMed
3) Mac Manus MP, Hoppe RT. : Is radiotherapy curative for stage I and II low grade follicular Oncol 14 : 1282-1290, 1996
 
4) Hoskin PJ, Kirkwood AA, Popova B, et al. : 4Gy versus24Gy radiotherapy for patients, with indolent lymphoma (FORT) : a randomized phase 3 non-inferiority trial. Lancet Oncol 15 : 457-463, 2014
 
5) Miller TP, Dahlberg S, Cassady JR, et al. : Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate-and high-grade non-Hodgkin's lymphoma. N Eng J Med 339 : 21-26, 1998
 
6) Hornig SJ, Weller E, Kim K, et al. : Chemotherapy with or without radiotherapy in limited stage diffuse aggressive non-Hodgkin's lymphoma : Eastern Cooperative Oncology Group study 1484. J Clin Oncol 22 : 3032-3083, 2004
 
7) Bonnet C, Fillet G, Mounier N, et al. : CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients : a study by Goupe d'Etude des lymphomes de'Adulte. J Clin Oncol 25 : 787-792, 2007
 
8) Persky DO, Unger JM, Spier CM, et al. : Phase II study of rituximab plus CHOP and involved field radiotherapy for patients with limited stage aggressive B-cell lymphoma : Southweat Oncology Group study 0014. J Clin Oncol 26 : 2258-2263, 2008
 
9) Hass RL, Poortmans P, de Jong D et al. : Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients. Eur J Cancer 41 : 1724-1730, 2005
PubMed
10) 日本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016年版, 金原出版, 281-289, 2016
 
P.219 掲載の参考文献
1) Yahalom J, Illidge T, Specht L, et al. : International Lymphoma Radiation Oncology Group. Modern radiation therapy for extranodal lymphomas : field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 92 : 11-31, 2015
PubMed
2) NCCN Clinical Practice Guidelines in Oncology : Central nervous system cancers Version 1. 2015. http://www.nccn.org/professionals/physician_gls/pdf/cns.pdf
 
3) Thiel E, Korfel A, Martus P, et al. : High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1) : a phase 3, randomized, non-inferiority trial. Lancet Oncol 11 : 1036-1047, 2010
 
4) Zacher J, Kasenda B, Engert A, et al. : The role of additional radiotherapy for primary central nervous system lymphoma. Cochrane Database Syst Rev 6 : CD009211, 2014
PubMed
5) kasenda B, Ferreri AJ, Marturano E, et al. : First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL) -a systematic review and individual patient data meta-analysis. Ann Oncol. 26 : 1305-1313, 2015
PubMed
6) 日本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016年版. 金原出版, 290-299, 2016
 
7) NCCN Clinical Practice Guidelines in Oncology : Non-Hodgkin's lymphoma Version 2. 2015. http://www.nccn.org/professionals/physician_gls/pdf/nhl.pdf
 
8) Della Biancia C, Hunt M, Furhang E, et al. : Radiation treatment planning techniques for lymphoma of the stomach. Int J Radiat Oncol Biol Phys 62 : 745-751, 2005
PubMed
9) Yamaguchi M, Tobinai K, Oguchi M, et al. : Phase I/ll study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma : Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol 27 : 5594-5600, 2009
 
10) Yamaguchi M, Tobinai K, Oguchi M, et al. : Concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma : an updated analysis of the Japan clinical oncology group study JCOG0211. J Clin Oncol 30 : 4044-4046, 2012
 
11) 丹生健一, 佐々木良平, 大月直樹, 大田史江, 編 : 頭頸部がんの化学放射線療法, 日本看護協会出版会, 2015
 
P.224 掲載の参考文献
1) 日本血液学会 : 造血器腫瘍診療ガイドライン 2013年版. 金原出版, 2013
 
2) がん研究振興財団 : がんの統計 '16, 東京, 国立がん研究センターがん対策情報センター, 2017
 
3) NCCN Guidelines Multiple Myeloma. Bethesda, : The National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
 
4) Plasma Cell Neoplasms (lncluding Multiple Myeloma) Treatment (PDQ) ? Health Professional Version. Bethesda, National Cancer Institute, 2016 http://www.cancer.gov/types/myeloma/hp/myeloma-treatment-pdq
 
5) Dabaja B, Ha CS. : Leukemias and Plasma Cell Disorders. Haffty BG, Wilson LD, eds. Handbook of Radiation Oncology. Burlington, Jones & Bartlett Learning, 739-753, 2009
 
6) Hodgson DC, Mikhael J, Tsang RW. Plasma cell myeloma and Plasmacytoma. Halperin EC, Wazer DE, Perez CA, et al, eds. Principles and Practice of Radiation Oncology (6th edition). Philadelphia, Lippincott Williams & Wilkins, 1599-1608, 2013
 
7) Munshi NC, Anderson KC. Plasma Cell Neoplasms. Devita VT Jr, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg's Cancer Principles & Practice of Oncology (8th edition). Philadelphia, Lippincott Williams & Wilkins, 2305-2342, 2008
 
8) 河野道生 : 血液・造血器疾患を深く学ぼう C. 悪性リンパ腫と類縁疾患, 多発性骨髄腫. 小澤敬也, 直江知樹, 坂田洋一編. 講義録血液・造血器疾患学. 東京, メジカルビュー社, 226-231, 2008
 
9) 砂川好光 : 多発性骨髄腫と形質細胞腫. 兼平千裕. 青木学監訳 : 最新エビデンスに基づく放射線治療UCSF腫瘍医による実践ハンドブック. 東京, 中外医学社, 431-436, 2007
 
10) 西山謹司 : 骨髄腫. 平岡真寛, 笹井啓資, 井上俊彦編 : 放射線治療マニュアル (改訂第2版), 東京, 中外医学社, 501-505, 2006
 
11) 磯部公一 : 第7章 各領域の治療 7-72 骨髄腫・形質細胞腫. 大西洋, 唐澤久美子, 唐澤克之編, がん・放射線療法 2010. 東京, 篠原出版新社, 1102-1110, 2010
 
12) 日本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016年版. 金原出版, 301-305, 2016
 
13) Hu K, Yahalom J. Radiotherapy in the management of plasma cell tumors. Oncology (Williston Park) 14 : 101-108, 2000
PubMed
14) 丹生健一, 佐々木良平, 大月直樹, 大田史江, 編 : 頭頸部がんの化学放射線療法, 日本看護協会出版会, 2015
 
P.232 掲載の参考文献
1) Alam M, Ratner D. : Cutaneous squamous-cell carcinoma. N Engl J Med 344 : 975-983, 2001
PubMed
2) Bath-Hextall F, Bong J, Perkins W, et al. : Interventions for basall cell carcinoma of the skin : systematic review. BMJ 329 : 705, 2004
 
3) Chen AM, Grekin RC, Garcia J, et al. : Radiation therapy for cutaneous squamous cell carcinoma involving the parotid area lymph nodes : dose and volume considerations. Int J Radiat Oncol Biol Phys 69 : 1377-1380, 2007
PubMed
4) Neville JA, Welch E, Leffell DJ. : Management of nonmelanoma skin cancer in 2007. Nat Clin Pract Oncol 4 : 462-469, 2007
PubMed
5) Jackson JE, Dickie GJ. Wiltshire KL, et al. : Radiotherapy for perineural invasion in cutaneous head and neck carcinomas : toward a risk-adapted treatment approach. Head Neck 31 : 604-610, 2009
 
6) Han A, Ratner D. : What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion? Cancer 109 : 1053-1059, 2007
PubMed
7) McCord MW, Mendenhall WM, Parsons JT, et al. : Skin cancer of the head and neck with clinical perineural invasion. Int J Radiat Oncol Biol Phys 47 : 89-93, 2000
PubMed
8) Dummer R, Hauschild A, Guggenheim M, et al. : Cutaneous melanoma : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23 Suppl 7 : vii86-91, 2012
 
9) Grabe C, Peris K, Hauschild A, et al. : Diagnosis and treatment of melanoma : European consensus-based interdisciplinary guideline. Eur J Cancer 46 : 270-283, 2010
 
10) Guadagnolo BA, Zagars GK. : Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma. Lancet Oncol 10 : 409-416, 2009
PubMed
11) Testori A, Rutkowski P, Marsden J, et al. : Surgery and radiotherapy in the treatment of cutaneous Melanoma. Ann Oncol 20 Suppl 6 : vi22-29, 2009
 
12) Willemze R, Hodak E, Zinzani PL, et al. : Primary cutaneous lymphomas : ESMO clinical Practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 24 Suppl 6 : vi149-154, 2013
 
13) Young RJ, Brown NJ, Reed MW, et al. : Angiosarcoma. Lancet Oncol 11 : 983-991, 2010
PubMed
14) 日本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016年版. 金原出版, 306-310, 2016
 
15) Khan L, Choo R, Breen D, et al. : Recommendations for CTV margins in radiotherapy planning for non melanoma skin cancer. Radiother Oncol 104 : 263-266, 2012
PubMed
16) Spratt DE, Gordon Spratt EA, Romanyshyn JC, et al. : Radiation Therapy in the Treatment of Cutaneous Angiosarcoma of the Head and Neck. World J Surg Med Radiat Oncol 2 : 6-18, 2013
 
17) 日本皮膚科学会/日本皮膚悪性腫瘍学会 : 皮膚悪性腫瘍診療ガイドライン 第2版. 金原出版, 2015
 
18) Jones GW, Kacinski BM, Wilson LD, et al. : Total skin electron radiation in the management of mycosis fungoides : Consensus of the European Organization for Reseach and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group. J Am Acad Dermatol 47 : 364-370, 2002
 
19) 丹生健一, 佐々木良平, 大月直樹, 大田史江, 編 : 頭頸部がんの化学放射線療法, 日本看護協会出版会, 2015
 
P.237 掲載の参考文献
1) がん研究振興財団 : がんの統計 '16, ICD-10 三桁分類別がん死亡 (2015). 東京, 国立がん研究センターがん対策情報センター, 2016
 
2) Pisters PW, Pollock RE, Lewis VO, et al. : Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg 246 : 675-682, 2007
PubMed
3) DeLaney TF, Park L, Goldberg SI, et al. : Radiotherapy for local control of osteosarcoma. Int J Radiat Oncol Biol Phys 61 : 492-498, 2005
PubMed
4) Yang JC, Chang AE, Baker AR, et al. : Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Chin Oncol 16 : 197-203, 1998
 
5) Pollack A, Zagars GK, Goswitz MS, et al. : Preoperative vs. postoperative radiotherapy in the treatment of soft tissue sarcomas : a matter of presentation. Int J Radiat Oncol Biol Phys 42 : 563-572, 1998
PubMed
6) O'Sullivan B, Davis AM, Turcotte R, et al. : Preoperative Versus postoperative radiotherapy in soft-tissue sarcoma of the limbs : a randomized trial. Lancet 359 : 2235-2241, 2002
PubMed
7) Zagars GK, Ballo MT. : Sequencing radiotherapy for soft tissue sarcoma when re-resection is planned. Int J Radiat Oncol Biol Phys 56 : 21-27, 2003
PubMed
8) Davis AM, O'Sullivan B, Turcotte R, et al. : Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol 75 : 48-53, 2005
PubMed
9) 日本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016年版. 金原出版, 311-315, 2016
 
10) Oya N, Kokubo M, Mizowaki T, et al. : Definitive intraoperative very high-dose radiotherapy for localized osteosarcoma in the extremities. Int J Radiat Oncol Biol Phys 51 : 87-93, 2001
PubMed
11) Niewald M, Fleckenstein J, Licht N, et al. : Intraoperative radiotherapy (IORT) combined with beam radiotherapy (EBRT) for soft--tissue sarcomas-a retrospective evaluation of the Homburg experience in the years 1995-2007. Radiat Oncol 4 : 32, 2009
PubMed
12) Hayashi K, Araki N, Koizumi M, et al. : Long-term results of intraoperative extracorporeal irradiation of autogenous bone graft on primary bone and soft tissue malignancies. Acta Oncol 54 : 138-141, 2015
PubMed
13) Kamada T, Tsujii H, et al. : Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol 20 : 4466-4471, 2002
PubMed
14) Sugahara S, Kamada T, Imai R, Tsuji H, Kameda N, Okada T, Tsujii H, Tatezaki S : Working Group for the Bone and Soft Tissue Sarcomas. Carbon ion radiotherapy for localized primary sarcoma of the extremities : results of a phase I/H trial. Radiother Oncol 105 : 226-231, 2012
 
15) Nag S, Shasha D, Janjan N, et al. : The American Brachytherapy Society recommendations for brachytherapy of soft tissue sarcomas Int J Radiar Oncol Biol Phys 49 : 1033-1043, 2001
 
16) Holloway CL, Delaney IF, Alektiar KM, et al. : American Brachytherapy Society (ABS) consensus statement for sarcoma brachytherapy. Brachytherapy 12 : 179-190, 2013
PubMed
17) O'Sullivan B, et al. : Soft tissue sarcoma. Gunderson LL, Tepper JE, eds. Clinical Radiation Oncology 2nd ed. New York, Churchill Livingstone, pp1519-1549, 2006
 
18) Sleijfer S, Gorlia T, Lamers C, et al. : Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma : an EORTC-STBSG study. Br J Cancer 107 : 639-645, 2012
PubMed
19) Pisters PW, O'Sullivan B, Maki RG, : Evidence-based recommendations for local therapy for soft tissue sarcomas. J Clin Oncol 25 : 1003-1008, 2007
PubMed
20) Alektiar KM, Brennan MF, Healey JH, et al. : Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity. J Clin Oncol 26 : 3440-3444, 2008
PubMed
21) 丹生健一, 佐々木良平, 大月直樹, 大田史江, 編 : 頭頸部がんの化学放射線療法, 日本看護協会出版会, 2015
 
P.244 掲載の参考文献
1) がん診療ガイドライン, 日本癌治療学会, http://www.jsco-cpg.jp/guideline/05.html
 
2) Naruhiro MATSUFUJI et al. : Specification of Carbon Ion Dose at the National Institute of Radiological Sciences (NIRS), J. Radiat. Res., 48 : Suppl., A81-A86, 2007
 
3) Tadashi Kamada et al. : Carbon ion radiotherapy in Japan : an assessment of 20 years of clinical experience, Lancet Oncol : 16 : e93-100, 2015
PubMed
4) Hirohiko Tsujii et al : A Review of Update Clinical Results of Carbon Ion Radiotherapy, Jpn. J. Clin. Oncol., 2012
PubMed
5) Peter C. PARK et al. : A Beam-Specific Planning Target Volume (PTV) Design For Proton Therapy To Account For Setup And Range Uncertainties, Int. J. Radiation Oncology Biol. Phys., 2012
 
6) Urie M, Goitein M, Wagner M. : Compensating for Heterogeneities in Proton Radiation-Therapy. Physics in Medicine and Biology., 29 : 553-566, 1984
PubMed
7) Kamada T, et al. : Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol. 20 : 4466-4471, 2002
PubMed

Chapter 8 小児

P.246 掲載の参考文献
1) Tournade MF, Com-Nougue C, de Kraker J, et al. : Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months : results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study. J Clin Oncol 15 19 : 488-500, 2001
 
2) Silvan AM, Gordillo MJ, Lopez AM, et al. : Organ-preserving management of rhabdomyosarcoma of the prostate and bladder in children. Med Pediatr Oncol 29 : 573-575, 1997
PubMed
P.251 掲載の参考文献
1) 日本小児血液・がん学会, 編 : 小児がん診療ガイドライン 2011年版. 金原出版, 2014
 
2) Kapapurakal JA, Thomas PRM Wilms tumor. Halperin EC, Wazer DE Perez CA, et al. : Principles and Practice of Radiation Oncology (6th edition). Philadelphia, Lippincott Wilkins, pp 1655-1664, 2013
 
3) Paulino AC, Wen BC, Brown CK, et al. : Late effects in children treated with radiation therapy for Wilms' tumor. Int J Radiat Biol Phys 46 : 1239-1246, 2000
 
4) Dgler RM, Wolf JE, Anderson RA, et al. : Long-term complications and post-treatment follow-up of patients with Wilms' tumor. Semin Urol Oncol 17 : 55-61, 1999
 
5) Kapapurakal JA, Peterson S, Peabody EM, et al. : Pregnancy outcomes after abdominal irradiation that included or excluded the pelvis in childhood Wilms tumor survivor : a report from the National Wilms' Tumor Study Group. Int J Radiat Oncol Biol Phys 58 : 1364-1368, 2004
 
P.254 掲載の参考文献
1) Lawrence Jr W, Gehan EA, Hays DM, et al. : Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma : a report from the Intergroup Rhabdomyosarcoma Study (IRS-II). J Clin Oncol 5 : 46-54, 1987
 
2) Rodary C, Flamant F, Donaldson SS. : An attempt to use a common stagirlg system in rhabdomyosarcoma : a report of an international workshop initiated by the International Society of Pediatric Oncology (SIOP). Med Pediatr Oncol 17 : 210-215, 1989
PubMed
3) Michiaki JM, Meza J, Breneman JC, et al. : Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV. Irlt J Radiat Oncol Biol Phys 59 : 1027-38. (エビデンスレベル IVa), 2004
 
4) Raney RB, Walterhouse DO, Meza JL, et al. : Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma : a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. J Clin Oncol 29 : 1312-1318, 2011
 
5) Maurer HM, Beltangady M, Gehan EA, et al. : The Intergroup Rhabdomyosarcoma Study-1. A final report. Cancer 61 : 209-220, 1988
PubMed
P.257 掲載の参考文献
1) Maris JM, Hogarty MD, Bagatell R, et al. : Neuroblastoma. Lancet, 369 : 2106-20, 2007
PubMed
2) Pritchard J, Hickman JA. Why does stage 4s neuroblastoma regress spontaneously? Lancet, 344 : 869-70, 1994
PubMed
3) Gillis AM, Sutton E, Dewitt KD, et al. : Long-term outcome and toxicities of intraoperative radiotherapy for high-risk neuroblastoma. Int J Radiat Oncol Biol Phys, 69 : 858-64. (エビデンスレベル V), 2007
 
P.260 掲載の参考文献
1) Paulussen M, Ahrens S, Dunst J, et al : Localized Ewing tumor of bone : Final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 19 : 1818-1829, 2001
 
2) Grier HE, Krailo MD, Tarbell NJ, et al. : Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 348 : 694-701, 2003
 
3) Schuck A, Ahrens S, Paulussen M, et al. : Local therapy in localized Ewing tumors : results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Rad Oncol Biol Phys 55 : 168-177, (エビデンスレベル III), 2003
 
4) Bolling T, Schuck A, Paulussen M, et al. : Whole lung irradiation in patients with exclusively pulmonary metastases of Ewing tumors. Toxicity analysis and treatment results of the ElCESS-92 trial. Strahlenther Onkol, 184 : 193-7. (エビデンスレベル III), 2008
 
5) 日本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016年版, 金原出版, 2016
 
P.264 掲載の参考文献
1) Pui CH, Cheng C, Leung W, et al : Extended follow-up of long-term survivors of childhood acutelymphoblastic leukemia. N Engl J Med 349 : 640-649, (IV), 2003
 
2) 日本小児血液・がん学会, 編 : 小児がん診療ガイドライン 2011年版, 2011
 
3) 日本放射線腫瘍学会, 編 : 放射線治療計画ガイドライン 2016年版. 金原出版, 2016
 
4) Salooja N., Szydlo R. M., Socie G. et al. : Pregnancy outcomes after peripheral blood or bone marrow transplantation : a retrospective surgery. Lancet 358 : 271-276, 2001
PubMed
P.268 掲載の参考文献
1) Shane E. Cotter, M. D., Ph. D., : Proton Radiotherapy for Solid Tumors of Childhood, Technology in Cancer Research and Treatment, Volume 11, Number 3, June 2012
 
2) W. H. ST. CLAIR, : ADVANTAGE OF PROTONS COMPARED TO CONVENTIONAL X-RAY OR IMRT IN THE TREATMENT OF A PEDIATRIC PATIENT WITH MEDULLOBLASTOMA Int. J. Radiation Oncology Biol. Phys., Vol. 58, No. 3, pp. 727-734, 2004
 
3) Stephen R. Grant, : Proton versus conventional radiotherapy for pediatric salivary gland tumors : Acute toxicity and dosimetric characteristics, Radiotherapy and Oncology 116, 309-315, 2015
PubMed
4) Peter C. PARK et al. : A Beam-Specific Planning Target Volume (PTV) Design For Proton Therapy To Account For Setup And Range Uncertainties, Int. J. Radiation Oncology Biol. Phys., 2012
 
5) Urie M, Goitein M, Wagner M. : Compensating for Heterogeneities in Proton Radiation-Therapy. Physics in Medicine and Biology., 29 : 553-566, 1984
PubMed
6) Masashi Mizumoto. : Preparation of pediatric patients for treatment with proton beam therapy, Radiotherapy and Oncology 114, 245-248, 2015
PubMed

Chapter 9 緩和

P.272 掲載の参考文献
1) Patchell RA, Tibbs PA, Regine WF, et al. : Postoperative radiotherapy in the treatment of single metastases to the brain. JAMA. 280 : 1485-1489. 1998
 
2) Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary Jp, Souhami L, et al. : Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases : phase III results of the RTOG 9508 randomised trial. Lancet. 363, 1665-1672, 2004
PubMed
3) Aoyama H, Shirato H, Tago M, et al. : Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases : A Randomized Controlled Trial. JAMA 295 : 2483-2491, 2006
PubMed
4) Kurtz JM, Gelber R, Brady LW, Carella RJ, Cooper JS. : The palliation of brain metastases in a favorable patient population : a randomized clinical trial by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 7 : 891-895, 1981
 
5) Gaspar L, Scott C, Rotman M, et al. : Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37 : 745-751. 1997
PubMed
6) Murray KJ, Scott C, Zachariah B, Michalski JM, Demas W, Vora NL, et al. : Importance of the mini-mental status examination in the treatment of patients with brain metastases : a report from the Radiation Therapy Oncology Group protocol 91-04. Int J Radiat Oncol Biol Phys. 48 : 59-64, 2000
PubMed
P.275 掲載の参考文献
1) Janjan NA. : An emerging respect for palliative care in radiation oncology. J Palliat Med 1 : 83-88, 1998
PubMed
2) 小泉満 : 骨転移. The Bone 18 : 583-586, 2004
Medical*Online
3) Chow E, Zeng L, Salvo N, et al. : Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol (R Coll Radiol) 24 : 112-124, 2012
PubMed
4) Lutz S, Berk L, Chang E, et al. : Palliative radiotherapy for bone metastases : an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 79 : 965-976, 2011
PubMed
5) Chow E, van der Linden YM, Roos D, et al. : Single versus multiple fractions of repeat radiation for painful bone metastases : a randomised, controlled, non-inferiority trial. Lancet Oncol. 15. 164-171, 2014
PubMed
6) Townsend PW, Rosenthal HG, Smalley SR, Cozad SC, Hassanein RE. : Impact of postoperative radiation therapy and other perioperative factors on outcome after orthopedic stabilization of impending or pathologic fractures due to metastatic disease. J Clin Oncol 12. 2345-50, 1994
PubMed
7) Souchon R, Wenz F, Sedlmayer F, et al. : DEGRO practice guidelines for palliative radiotherapy of metastatic breast cancer : Bone metastases and metastatic spinal cord compression (MSCC) Strahlenther Onkol 185. 417-424, 2009
PubMed
8) Chow E, Wong R, Hruby G, et al. : Prospective patient-based assessment of effectiveness of palliative radiotherapy for bone metastases. Radiother Oncol 61. 77-82, 2001
PubMed
9) Steenland E, Leer JW, van Houwelingen H, et al. : The effect of a single fraction compared to multiple fractions on painful bone metastases : a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol. 52. 101-109, 1999
PubMed
10) 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain : randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party. Radiother Oncol 52. 111-121, 1999
PubMed
11) Hayashi S, Hoshi H, Iida T. : Reirradiation with local field radiotherapy for painful bone metastases. Radiat Med 20. 231-236, 2002
PubMed
P.279 掲載の参考文献
1) Loblaw DA, Laperriere NJ, Mackillop WJ. : A population-based study of malignant spinal cord compression in Ontario. Clin Oncol (R Coll Radiol), Jun : 15 (4) : 211-7, 2003
PubMed
2) Helweg-Larsen S, Sorensen PS. : Symptoms and signs in metastatic spinal cord compression : a study from first symptom until diagnosis in 153 patients. European Journal of Cancer. 30 (A) : 396-8, 1994
 
3) Rades D, Fehlauer F, Stalpers LJ, et al : A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression : final results of a multicenter study. Cancer. 101 : 2687-2692. 2004
PubMed
4) Rades D, Stalpers LJ, Veninga T, et al : Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol. 23 : 3366-3375. 2005
PubMed
5) Rades D, Huttenlocher S, Bajrovic A, et al. : Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors. Int J Radiat Oncol Biol Phys 81. e861-868. 2001
 
6) Loblaw DA, Laperriere NJ, et al : Emergency treatment of malignant extradural spinal cord compression : An evidence-based guideline. J Clin Oncol 16 : 1613-1624, 1998
PubMed
7) Rades D, Douglas S, Huttenlocher S, et al. : Validation of a score predicting post-treatment ambulatory status after radiotherapy for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 79 : 1503-1506, 2011
PubMed
8) 唐澤久美子, 編 : がん放射線治療の理解とケア, Nursing Mook 43, 学習研究社, 2007
 
P.282 掲載の参考文献
1) Armstrong B, Perez C, Simpson J, et al. : Role of irradiation in the management of superior vena cava syndrome. Int J Radiat Oncol Biol Phys 13 : 531-539, 1987
PubMed
2) 唐澤久美子, 編 : がん放射線治療の理解とケア, Nursing Mook 43, 学習研究社, 2007
 
3) 菱川良夫, 監修 : 看護の力でQOLを向上させる! 放射線治療を受けるがん患者の看護ケア, 日本看護協会出版会, 2008
 

書評

最近チェックした商品履歴

Loading...